Insider filing · CRBP
Yuval Cohen
Chief Executive Officer
profile →
Corbus Pharmaceuticals Holdings, Inc.
CRBP · Healthcare · 7 filings in 24 months
ticker →
Yuval Cohen sold $471K of Corbus Pharmaceuticals (CRBP)
Executed Oct 24 2025, disclosed Oct 27 2025, 3 days later.
Value, as filed
$471K
27,633 sh across 2 lots
Executed
Oct 24 2025
the trade date, as filed
Disclosed
Oct 27 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
YCYuval Cohen (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $171K of CRBP (17,000 sh × $10.08, as filed), executed Aug 7.
The name
CRBPHealthcare · Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Yuval Cohen in CRBP
CRBPSALE
Corbus Pharmaceuticals Holdings, Inc.
$171K17,000 sh × $10.08
Exec Aug 7
Filed Aug 10 · 4:30 PM ET CRBPSALE Corbus Pharmaceuticals Holdings, Inc. $108K
13,871 sh × $7.78
Exec Feb 13
Filed Feb 18 · 5:30 PM ET